These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 32897166
1. Two types of colistin heteroresistance in Acinetobacter baumannii isolates. Hong YK, Kim H, Ko KS. Emerg Microbes Infect; 2020 Dec; 9(1):2114-2123. PubMed ID: 32897166 [Abstract] [Full Text] [Related]
2. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment. Jo J, Kwon KT, Ko KS. J Biomed Sci; 2023 Jun 07; 30(1):37. PubMed ID: 37287044 [Abstract] [Full Text] [Related]
3. Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii. Çağlan E, Nigiz Ş, Sancak B, Gür D. Acta Microbiol Immunol Hung; 2020 Jun 01; 67(2):107-111. PubMed ID: 31813259 [Abstract] [Full Text] [Related]
4. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii. Jo J, Ko KS. Microbiol Spectr; 2021 Oct 31; 9(2):e0101021. PubMed ID: 34523993 [No Abstract] [Full Text] [Related]
5. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China. Chen L, Lin J, Lu H, Zhang X, Wang C, Liu H, Zhang X, Li J, Cao J, Zhou T. J Antibiot (Tokyo); 2020 Jul 31; 73(7):463-470. PubMed ID: 32152526 [Abstract] [Full Text] [Related]
6. Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital. Thet KT, Lunha K, Srisrattakarn A, Lulitanond A, Tavichakorntrakool R, Kuwatjanakul W, Charoensri N, Chanawong A. World J Microbiol Biotechnol; 2020 Jul 01; 36(7):102. PubMed ID: 32613355 [Abstract] [Full Text] [Related]
7. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance. Rodriguez CH, Traglia G, Bastias N, Pandolfo C, Bruni G, Nastro M, Barrios R, Bavastro EM, Rey MC, Marques IA, Heger F, Vay C, Fernandez JS, Ramirez MS, Famiglietti A. Int J Antimicrob Agents; 2019 Nov 01; 54(5):587-591. PubMed ID: 31400469 [Abstract] [Full Text] [Related]
8. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients. Haeili M, Kafshdouz M, Feizabadi MM. Microb Drug Resist; 2018 Nov 01; 24(9):1271-1276. PubMed ID: 29590004 [Abstract] [Full Text] [Related]
18. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii. Charretier Y, Diene SM, Baud D, Chatellier S, Santiago-Allexant E, van Belkum A, Guigon G, Schrenzel J. Antimicrob Agents Chemother; 2018 Sep 01; 62(9):. PubMed ID: 29914966 [Abstract] [Full Text] [Related]
20. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. Yau W, Owen RJ, Poudyal A, Bell JM, Turnidge JD, Yu HH, Nation RL, Li J. J Infect; 2009 Feb 01; 58(2):138-44. PubMed ID: 19058855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]